Limitations, agreements, and source contact

Trial of Afatinib in Pediatric Tumours · Source last updated 2021-03-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restriction Type

LTE60

restrictive Agreement

true

point Of Contact

email

clintriage.rdg@boehringer-ingelheim.com

organization

Boehringer Ingelheim

phone

1-800-243-0127

title

Boehringer Ingelheim, Call Center

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice